Kancera AB (publ) Cash Flow Conversion Efficiency

Latest as of June 2025: -0.227x

Kancera AB (publ) cash flow conversion efficiency. Based on the latest financial reports, Kancera AB (publ) (KAN) has a cash flow conversion efficiency ratio of -0.227x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-9.80 Million ≈ $-1.05 Million USD) by net assets (Skr43.12 Million ≈ $4.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Kancera AB (publ) (2010–2024)

Cash flow conversion efficiency of Kancera AB (publ) from 2010 to 2024. This chart illustrates how Kancera AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Kancera AB (publ) for real-time trading data and today's change.

Kancera AB (publ) Cash Flow Conversion Ratio Explained

Kancera AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Kancera AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kancera AB (publ) ranked by their cash flow conversion efficiency. Also see KAN market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Dotdigital Group Plc LSE:DOTD	0.067x
iSpecimen Inc NASDAQ:ISPC	-0.397x
GoldOn Resources Ltd V:GLD	-0.098x
Crest Nicholson Holdings plc LSE:CRST	-0.142x
Asiamet Resources Ltd F:0FK	-4.045x
EF EnergyFunders Ventures Inc V:EFV	0.007x
Fitell Corporation Ordinary Shares NASDAQ:FTEL	-0.030x
Divio Technologies AB Series B ST:DIVIO-B	0.255x

Annual Cash Flow Conversion Efficiency for Kancera AB (publ) (2010–2024)

The table below shows the annual cash flow conversion efficiency of Kancera AB (publ) from 2010 to 2024. Review KAN FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr62.30 Million ≈ $6.70 Million	Skr-58.53 Million ≈ $-6.30 Million	-0.940x	+19.56%
2023-12-31	Skr47.66 Million ≈ $5.13 Million	Skr-55.67 Million ≈ $-5.99 Million	-1.168x	-162.54%
2022-12-31	Skr106.91 Million ≈ $11.51 Million	Skr-47.56 Million ≈ $-5.12 Million	-0.445x	-23.54%
2021-12-31	Skr122.54 Million ≈ $13.19 Million	Skr-44.12 Million ≈ $-4.75 Million	-0.360x	+43.47%
2020-12-31	Skr72.28 Million ≈ $7.78 Million	Skr-46.05 Million ≈ $-4.96 Million	-0.637x	+66.66%
2019-12-31	Skr17.42 Million ≈ $1.87 Million	Skr-33.29 Million ≈ $-3.58 Million	-1.911x	-41.51%
2018-12-31	Skr33.36 Million ≈ $3.59 Million	Skr-45.04 Million ≈ $-4.85 Million	-1.350x	+2.37%
2017-12-31	Skr38.71 Million ≈ $4.17 Million	Skr-53.54 Million ≈ $-5.76 Million	-1.383x	-256.36%
2016-12-31	Skr59.52 Million ≈ $6.41 Million	Skr-23.10 Million ≈ $-2.49 Million	-0.388x	+58.81%
2015-12-31	Skr21.93 Million ≈ $2.36 Million	Skr-20.66 Million ≈ $-2.22 Million	-0.942x	-34.58%
2014-12-31	Skr27.29 Million ≈ $2.94 Million	Skr-19.11 Million ≈ $-2.06 Million	-0.700x	-99.93%
2013-12-31	Skr18.96 Million ≈ $2.04 Million	Skr-6.64 Million ≈ $-714.35K	-0.350x	+92.89%
2012-12-31	Skr5.50 Million ≈ $591.78K	Skr-27.08 Million ≈ $-2.91 Million	-4.925x	-449.52%
2011-12-31	Skr25.90 Million ≈ $2.79 Million	Skr-23.21 Million ≈ $-2.50 Million	-0.896x	-75.76%
2010-12-31	Skr11.07 Million ≈ $1.19 Million	Skr-5.64 Million ≈ $-607.38K	-0.510x	--

About Kancera AB (publ)

ST:KAN Sweden Biotechnology

Market Cap

$1.98 Million

Skr18.44 Million SEK

Market Cap Rank

#30045 Global

#679 in Sweden

Share Price

Skr0.15

Change (1 day)

-23.82%

52-Week Range

Skr0.15 - Skr0.23

All Time High

Skr38.15